Micromedic announces distribution agreement in Germany

Micromedic announces an exclusive distribution agreement to commercialize CellDetect in Germany


Zetiq Technologies, a fully-owned subsidiary of Micromedic, has entered into an exclusive distribution agreement with a German diagnostics company to commercialize its CellDetect kit for the monitoring of bladder cancer recurrence.

Link to complete article (Hebrew) 

More News/Information
© Micromedic Technologies Ltd. site mapcontact
Site by Site2goal | Design Studio Michal Lehavi